SCHEMBL5956824

SCHEMBL5956824

COC(=O)c1cc2c(cc1Cl)[C@H](O)CCS2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CA2 P00918 2/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 1/20 0.35
SLC6A3 Q01959 2/20 0.34
SERPINH1 P50454 1/20 0.34
USP2 O75604 1/20 0.34
ABL1 P00519 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5956637 1.00 MEN1 (0.38) MEN1KMT2ALMNASMN1; SMN2CA2
SCHEMBL5956628 0.85 KMT2A (0.38) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL5956889 0.85 KMT2A (0.38) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL5956701 0.85 KMT2A (0.41) MEN1KMT2ALMNACA2MAPT
SCHEMBL5956849 0.85 KMT2A (0.41) MEN1KMT2ALMNACA2MAPT
SCHEMBL5956638 0.84 GAA (0.40) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL5956605 0.84 GAA (0.40) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL5956898 0.83 CA2 (0.38) MEN1KMT2ALMNASMN1; SMN2CA2
SCHEMBL5956635 0.78 KMT2A (0.40) MEN1KMT2ACA2GAAUSP2
SCHEMBL5956821 0.78 KMT2A (0.40) MEN1KMT2ACA2GAAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1270570-B1 AMIDE COMPOUNDS AND USE THEREOF MITSUBISHI PHARMA CORP (JP) 2006-05-31 EP disclosed
US-6933305-B2 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2005-08-23 US disclosed
US-20030158413-A1 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2003-08-21 US disclosed
EP-1270570-A1 AMIDE COMPOUNDS AND USE THEREOF Mitsubishi Pharma Corporation (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158413-A1 Amide compounds and use thereof ROCK2, ROCK1, RHOT2 MEN1 2543/4885KMT2A 1253/4885LMNA 3962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.